Publication of Supplementary ProspectusSource: RNS
Publication of Supplementary Prospectus
The following supplementary prospectus has been approved by the Financial Conduct Authority and is available for viewing:
The supplementary prospectus dated 24 March 2020 (the "Supplementary Prospectus") relating to the base prospectus of Australia and New Zealand Banking Group Limited ("ANZBGL") dated 21 May 2019 (the "Base Prospectus") prepared in connection with the US$60,000,000,000 Euro Medium Term Note Programme established by ANZBGL (as Issuer), ANZ Bank New Zealand Limited (as Issuer and Guarantor of Notes issued by ANZ New Zealand (Int'l) Limited ("ANZNIL")) and ANZNIL (as Issuer).
To view the full Supplementary Prospectus, please paste the following URL into the address bar of your browser:
A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM.
For further information, please contact:
Australia and New Zealand Banking Group Limited
Phone: +61 (03) 8654 7597
Fax: +61 (03) 8542 5252
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus, as supplemented, is not addressed. Prior to relying on the information contained in the Base Prospectus, as supplemented, you must ascertain from the Base Prospectus, as supplemented, whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirements.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com or visit www.rns.com.